Propranolol therapy for secondary hyperparathyroidism in uraemia

Neuropeptide Y potentiates the N-methyl-D-aspartate response in the CA3 dorsal hippocampus. II. Involvement of a subtype of sigma receptor.

The Journal of pharmacology and experimental therapeutics·1992

Nonadrenergic and noncholinergic arterial dilatation and venoconstriction are mediated by calcitonin gene-related peptide1 and neurokinin-1 receptors, respectively, in the mesenteric vasculature of the rat after perivascular nerve stimulation.

The Journal of pharmacology and experimental therapeutics·1992

Neuropeptide Y potentiates selectively the N-methyl-D-aspartate response in the rat CA3 dorsal hippocampus. I. Involvement of an atypical neuropeptide Y receptor.

The Journal of pharmacology and experimental therapeutics·1992

Neuropeptide Y inhibits alpha-MSH release from rat hypothalamic slices through a pertussis toxin-sensitive G protein.

Brain research·1992

Ketodiet, physiological calcium intake and native vitamin D improve renal osteodystrophy.

Kidney international·1992

Immunohistochemical distribution and biological activity of pituitary adenylate cyclase-activating polypeptide (PACAP) in the central nervous system of the frog Rana ridibunda.

The Journal of comparative neurology·1992

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

Pharmacist-led educational intervention for rational prescribing and deprescribing of proton pump inhibitors in cancer patients: A quasi-experimental study from Pakistan.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026

Supporting effective anticipatory prescribing in end of life care.

Nursing standard (Royal College of Nursing (Great Britain) : 1987)·2026

Medication transitions and predictors of illicit substance use during opioid agonist treatment: a three-year follow-up study.

Addiction science & clinical practice·2026

Real-Time Prescription Benefit Tool Availability and Prescription Medication Fill Rates: A Post Hoc Analysis of a Cluster Randomized Clinical Trial.

JAMA health forum·2026

Development of a park and green space service classification to support park prescribing in Korea.

Frontiers in public health·2026

Current practice and guideline adherence in renal dose adjustment for patients with chronic kidney disease: A systematic review and meta-analysis.

British journal of clinical pharmacology·2026

Related Experiment Videos

Propranolol therapy for secondary hyperparathyroidism in uraemia

Related Concept Videos

Neuropeptide Y potentiates the N-methyl-D-aspartate response in the CA3 dorsal hippocampus. II. Involvement of a subtype of sigma receptor.

Nonadrenergic and noncholinergic arterial dilatation and venoconstriction are mediated by calcitonin gene-related peptide1 and neurokinin-1 receptors, respectively, in the mesenteric vasculature of the rat after perivascular nerve stimulation.

Neuropeptide Y potentiates selectively the N-methyl-D-aspartate response in the rat CA3 dorsal hippocampus. I. Involvement of an atypical neuropeptide Y receptor.

Neuropeptide Y inhibits alpha-MSH release from rat hypothalamic slices through a pertussis toxin-sensitive G protein.

Ketodiet, physiological calcium intake and native vitamin D improve renal osteodystrophy.

Immunohistochemical distribution and biological activity of pituitary adenylate cyclase-activating polypeptide (PACAP) in the central nervous system of the frog Rana ridibunda.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Pharmacist-led educational intervention for rational prescribing and deprescribing of proton pump inhibitors in cancer patients: A quasi-experimental study from Pakistan.

Supporting effective anticipatory prescribing in end of life care.

Medication transitions and predictors of illicit substance use during opioid agonist treatment: a three-year follow-up study.

Real-Time Prescription Benefit Tool Availability and Prescription Medication Fill Rates: A Post Hoc Analysis of a Cluster Randomized Clinical Trial.

Development of a park and green space service classification to support park prescribing in Korea.

Current practice and guideline adherence in renal dose adjustment for patients with chronic kidney disease: A systematic review and meta-analysis.

Related Experiment Videos

Propranolol therapy for secondary hyperparathyroidism in uraemia

Related Concept Videos

Related Articles